Histidine decarboxylase knockout mice, a genetic model of Tourette syndrome, show repetitive grooming after induced fear

Neuroscience Letters

Volumn 595, Issue , 2015, Pages 50-53

  Xu, Meiyu ^a   Li, Lina ^a   Ohtsu, Hiroshi ^b   Pittenger, Christopher ^a,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOHOKU UNIVERSITY   (Japan)

^c YALE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Histamine; Histidine decarboxylase; Stereotypical behavior; Stress; Tics; Tourette syndrome

Indexed keywords

DEXAMPHETAMINE; HISTIDINE DECARBOXYLASE;

ACUTE STRESS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; FACE VALIDITY; FEAR; FOOTSHOCK; FREEZING; GENE MUTATION; GENETIC MODEL; GILLES DE LA TOURETTE SYNDROME; GROOMING; HETEROZYGOTE; KNOCKOUT MOUSE; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY; ANIMAL; AUDITORY STIMULATION; CONDITIONED REFLEX; GENETICS; PSYCHOLOGY;

ACOUSTIC STIMULATION; ANIMALS; CONDITIONING, CLASSICAL; FEAR; GROOMING; HISTIDINE DECARBOXYLASE; MICE, KNOCKOUT; TOURETTE SYNDROME;

EID: 84927129275     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.03.067     Document Type: Article

References (42)

1. Leckman J.F. Tourette's syndrome. Lancet 2002, 360(9345):1577-1586.
2. Kurlan R. Clinical practice. Tourette's syndrome. N. Engl. J. Med. 2010, 363(24):2332-2338.
3. Scahill L., Tanner C., Dure L. The epidemiology of tics and Tourette syndrome in children and adolescents. Adv. Neurol. 2001, 85:261-271.
4. Williams K., Bloch M.H., State M.W., Pittenger C. Tourette syndrome and tic disorders. Neurobiology of Mental Illness 2013, Oxford, New York. fourth ed. D.S. Charney, J.D. Buxbaum, P. Sklar, E.J. Nestler (Eds.).
5. Bloch M.H. Emerging treatments for Tourette's disorder. Curr. Psychiatry Rep. 2008, 10(4):323-330.
6. Roessner V., et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur. Child Adolesc. Psychiatry 2011, 20(4):173-196.
7. Leckman J.F., Bloch M.H., Smith M.E., Larabi D., Hampson M. Neurobiological substrates of Tourette's disorder. J. Child Adolesc. Psychopharmacol. 2010, 20(4):237-247.
8. Cauchi R.J., Tárnok Z. Genetic animal models of Tourette syndrome: the long and winding road from lab to clinic. Trans. Neurosci. 2012, 3(2):153-159.
9. Godar S.C., Mosher L.J., Di Giovanni G., Bortolato M. Animal models of tic disorders: a translational perspective. J. Neurosci. Methods 2014, 238:54-69.
10. Macri S., Proietti Onori M., Laviola G. Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome. Neurosci. Biobehav. Rev. 2013, 37(6):1085-1100.
11. Pittenger C. Animal models of Tourette syndrome and obsessive-compulsive disorder. Animal Models of Movement Disorders 2014, Elsevier: Academic Press, San Deigo, pp. 748-766. M. LeDoux (Ed.).
12. Davis L.K., et al. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 2013, 9(10):e1003864.
13. State M.W. The genetics of Tourette disorder. Curr. Opin. Genet. Dev. 2011, 21(June 3):302-309.
14. Fernandez T., State M.W., Pittenger C. Tourette syndrome and tic disorders. Neurogenetics: Handbook of Clinical Neurology 2015, Elsevier, New York. D.H. Geschwind, H.L. Paulson (Eds.).
15. Ercan-Sencicek A.G., et al. L-Histidine decarboxylase and Tourette's syndromel. N. Engl. J. Med. 2010, 20:1901-1908. 362.
16. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev. 2008, 88(3):1183-1241.
17. Karagiannidis I., et al. Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J. Med. Genet. 2013, 50(11):760-764.
18. Fernandez T.V., et al. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol. Psychiatry 2012, 71(5):392-402.
19. Castellan Baldan L., et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 2014, 81(1):77-90.
20. Swerdlow N.R. Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette syndrome. Neurosci. Biobehav. Rev. 2013, 37(6):1150-1156.
21. Denys D., et al. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 2013, 23(11):1423-1431.
22. Wong D.F., et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2008, 33(6):1239-1251.
23. Rapanelli M., et al. Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of Tourette syndrome. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 2014, 24(12):1896-1906.
24. Pittenger C. Animal models of Tourette syndrome and obsessive-compulsive disorder. Animal Models of Movement Disorders 2014, Elsevier: Academic Press, San Deigo. M. LeDoux (Ed.).
25. Lin H., et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J. Child Psychol. Psychiatry Allied Discip. 2007, 48(2):157-166.
26. Buse J., Kirschbaum C., Leckman J.F., Munchau A., Roessner V. The modulating role of stress in the onset and course of Tourette's syndrome: a review. Behav. modif. 2014, 38(2):184-216.
27. Bornstein R.A., Stefl M.E., Hammond L. A survey of Tourette syndrome patients and their families: the 1987 Ohio Tourette survey. J. Neuropsychiatry Clin. Neurosci. 1990, 2(3):275-281.
28. Ohtsu H., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 2001, 502(1-2):53-56.
29. Pittenger C., et al. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 2002, 34(3):447-462.
30. Shmelkov S.V., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat. Med. 2010, 16(5):598-602. 591 p. following 602.
31. Welch J.M., et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448(7156):894-900.
32. Scharf J.M., Miller L.L., Mathews C.A., Ben-Shlomo Y. Prevalence of Tourette syndrome and chronic tics in the population-based Avon longitudinal study of parents and children cohort. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51(2):192-201. e195.
33. Reese H.E., et al. Mindfulness-based stress reduction for Tourette syndrome and chronic tic disorder: a pilot study. J. Psychosomat. Res. 2015, 78(March (3)):293-82014.
34. Liu L., et al. Improved learning and memory of contextual fear conditioning and hippocampal CA1 long-term potentiation in histidine decarboxylase knock-out mice. Hippocampus 2007, 17(8):634-641.
35. Gong Y.X., et al. Ameliorating effect of histamine on impairment of cued fear extinction induced by morphine withdrawal in histidine decarboxylase gene knockout mice. Acta Pharmacol. Sin. 2010, 31(11):1431-1437.
36. Dere E., et al. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur. J. Neurosci. 2004, 20(4):1051-1058.
37. Joshi V.V., Balsara J.J., Jadhav J.H., Chandorkar A.G. Effect of l-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice. Eur. J. Pharmacol. 1981, 69(4):499-502.
38. Paul V.N., Chopra K., Kulkarni S.K. Modulation of motor functions involving central dopaminergic system by l-histidine. Indian J. Exp. Biol. 2000, 38(10):988-993.
39. Saka E., Goodrich C., Harlan P., Madras B.K., Graybiel A.M. Repetitive behaviors in monkeys are linked to specific striatal activation patterns. J. Neurosci. Off. J. Soc. Neurosci. 2004, 24(34):7557-7565.
40. Ellender T.J., Huerta-Ocampo I., Deisseroth K., Capogna M., Bolam J.P. Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. J. Neurosci. Off. J. Soc. Neurosci. 2011, 31(43):15340-15351.
41. Krusong K., et al. High levels of histidine decarboxylase in the striatum of mice and rats. Neurosci. Lett. 2011, 495(2):110-114.
42. Wang Z., et al. The neural circuits that generate tics in Tourette's syndrome. Am. J. Psychiatry 2011, 168(12):1326-1337.